Vanberra Signal

MGeneRx

Curated by Signal

Provider of AI-based mobile app for identification of genetic disorders in pediatric patients

Overview

Provider of AI-based mobile app for identification of genetic disorders in pediatric patients. It aids in the early detection of chromosomal anomalies and phenotypes of a genetic condition in children under the age of one year. Also, it helps to develop solutions for congenital birth problems by detecting them early and offering early diagnosis and treatment options.

Key facts

Founded
2021

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • App based fitness journal

    Health TechnologyNew York City, United States
  • Provider of accessible healthcare services for diabetics

    Health TechnologyMiami, United States
  • Provides EHR and browser-based electronic Practice Management (PM) systems.

    Health TechnologyCharlotte, United States

About MGeneRx

What does MGeneRx do?

Provider of AI-based mobile app for identification of genetic disorders in pediatric patients.

Where is MGeneRx headquartered?

MGeneRx is headquartered in Morrisville, United States.

When was MGeneRx founded?

MGeneRx was founded in 2021.

Which sector is MGeneRx in?

MGeneRx operates in Health Technology.

Who are MGeneRx's competitors?

Companies similar to MGeneRx include Fitjour, MeringRx, and Agastha.